Venkatesh Thiruganasambandamoorthy1, Kenneth Kwong2, George A Wells2, Marco L A Sivilotti2, Muhammad Mukarram2, Brian H Rowe2, Eddy Lang2, Jeffrey J Perry2, Robert Sheldon2, Ian G Stiell2, Monica Taljaard2. 1. Departments of Emergency Medicine (Thiruganasambandamoorthy, Perry, Stiell) and of Epidemiology and Community Medicine (Thiruganasambandamoorthy, Kwong, Wells, Perry, Stiell, Taljaard), University of Ottawa; Ottawa Hospital Research Institute (Thiruganasambandamoorthy, Kwong, Mukarram, Perry, Stiell, Taljaard), The Ottawa Hospital, Ottawa, Ont.; Departments of Emergency Medicine (Sivilotti) and of Biomedical and Molecular Sciences (Sivilotti), Queen's University, Kingston, Ont.; Department of Emergency Medicine and School of Public Health (Rowe), University of Alberta, Edmonton, Alta.; Departments of Emergency Medicine (Lang) and Medicine (Sheldon), University of Calgary, Calgary, Alta. vthirug@ohri.ca. 2. Departments of Emergency Medicine (Thiruganasambandamoorthy, Perry, Stiell) and of Epidemiology and Community Medicine (Thiruganasambandamoorthy, Kwong, Wells, Perry, Stiell, Taljaard), University of Ottawa; Ottawa Hospital Research Institute (Thiruganasambandamoorthy, Kwong, Mukarram, Perry, Stiell, Taljaard), The Ottawa Hospital, Ottawa, Ont.; Departments of Emergency Medicine (Sivilotti) and of Biomedical and Molecular Sciences (Sivilotti), Queen's University, Kingston, Ont.; Department of Emergency Medicine and School of Public Health (Rowe), University of Alberta, Edmonton, Alta.; Departments of Emergency Medicine (Lang) and Medicine (Sheldon), University of Calgary, Calgary, Alta.
Abstract
BACKGROUND: Syncope can be caused by serious conditions not evident during initial evaluation, which can lead to serious adverse events, including death, after disposition from the emergency department. We sought to develop a clinical decision tool to identify adult patients with syncope who are at risk of a serious adverse event within 30 days after disposition from the emergency department. METHODS: We prospectively enrolled adults (age ≥ 16 yr) with syncope who presented within 24 hours after the event to 1 of 6 large emergency departments from Sept. 29, 2010, to Feb. 27, 2014. We collected standardized variables at index presentation from clinical evaluation and investigations. Adjudicated serious adverse events included death, myocardial infarction, arrhythmia, structural heart disease, pulmonary embolism, serious hemorrhage and procedural interventions within 30 days. RESULTS: We enrolled 4030 patients with syncope; the mean age was 53.6 years, 55.5% were women, and 9.5% were admitted to hospital. Serious adverse events occurred in 147 (3.6%) of the patients within 30 days after disposition from the emergency department. Of 43 candidate predictors examined, we included 9 in the final model: predisposition to vasovagal syncope, heart disease, any systolic pressure reading in the emergency department < 90 or > 180 mm Hg, troponin level above 99th percentile for the normal population, abnormal QRS axis (< -30° or > 100°), QRS duration longer than 130 ms, QTc interval longer than 480 ms, emergency department diagnosis of cardiac syncope and emergency department diagnosis of vasovagal syncope (C statistic 0.88, 95% confidence interval [CI] 0.85-0.90; optimism 0.015; goodness-of-fit p = 0.11). The risk of a serious adverse event within 30 days ranged from 0.4% for a score of -3 to 83.6% for a score of 11. The sensitivity was 99.2% (95% CI 95.9%-100%) for a threshold score of -2 or higher and 97.7% (95% CI 93.5%-99.5%) for a threshold score of -1 or higher. INTERPRETATION: The Canadian Syncope Risk Score showed good discrimination and calibration for 30-day risk of serious adverse events after disposition from the emergency department. Once validated, the tool will be able to accurately stratify the risk of serious adverse events among patients presenting with syncope, including those at low risk who can be discharged home quickly.
BACKGROUND:Syncope can be caused by serious conditions not evident during initial evaluation, which can lead to serious adverse events, including death, after disposition from the emergency department. We sought to develop a clinical decision tool to identify adult patients with syncope who are at risk of a serious adverse event within 30 days after disposition from the emergency department. METHODS: We prospectively enrolled adults (age ≥ 16 yr) with syncope who presented within 24 hours after the event to 1 of 6 large emergency departments from Sept. 29, 2010, to Feb. 27, 2014. We collected standardized variables at index presentation from clinical evaluation and investigations. Adjudicated serious adverse events included death, myocardial infarction, arrhythmia, structural heart disease, pulmonary embolism, serious hemorrhage and procedural interventions within 30 days. RESULTS: We enrolled 4030 patients with syncope; the mean age was 53.6 years, 55.5% were women, and 9.5% were admitted to hospital. Serious adverse events occurred in 147 (3.6%) of the patients within 30 days after disposition from the emergency department. Of 43 candidate predictors examined, we included 9 in the final model: predisposition to vasovagal syncope, heart disease, any systolic pressure reading in the emergency department < 90 or > 180 mm Hg, troponin level above 99th percentile for the normal population, abnormal QRS axis (< -30° or > 100°), QRS duration longer than 130 ms, QTc interval longer than 480 ms, emergency department diagnosis of cardiac syncope and emergency department diagnosis of vasovagal syncope (C statistic 0.88, 95% confidence interval [CI] 0.85-0.90; optimism 0.015; goodness-of-fit p = 0.11). The risk of a serious adverse event within 30 days ranged from 0.4% for a score of -3 to 83.6% for a score of 11. The sensitivity was 99.2% (95% CI 95.9%-100%) for a threshold score of -2 or higher and 97.7% (95% CI 93.5%-99.5%) for a threshold score of -1 or higher. INTERPRETATION: The Canadian Syncope Risk Score showed good discrimination and calibration for 30-day risk of serious adverse events after disposition from the emergency department. Once validated, the tool will be able to accurately stratify the risk of serious adverse events among patients presenting with syncope, including those at low risk who can be discharged home quickly.
Authors: James V Quinn; Ian G Stiell; Daniel A McDermott; Karen L Sellers; Michael A Kohn; George A Wells Journal: Ann Emerg Med Date: 2004-02 Impact factor: 5.721
Authors: Luis A Serrano; Erik P Hess; M Fernanda Bellolio; Mohammed H Murad; Victor M Montori; Patricia J Erwin; Wyatt W Decker Journal: Ann Emerg Med Date: 2010-10 Impact factor: 5.721
Authors: Matthew J Reed; David E Newby; Andrew J Coull; Keith G Jacques; Robin J Prescott; Alasdair J Gray Journal: Emerg Med J Date: 2007-04 Impact factor: 2.740
Authors: Venkatesh Thiruganasambandamoorthy; Erik P Hess; Abdullah Alreesi; Jeffrey J Perry; George A Wells; Ian G Stiell Journal: Ann Emerg Med Date: 2009-11-27 Impact factor: 5.721
Authors: Benjamin C Sun; Giorgio Costantino; Franca Barbic; Ilaria Bossi; Giovanni Casazza; Franca Dipaola; Daniel McDermott; James Quinn; Matthew Reed; Robert S Sheldon; Monica Solbiati; Venkatesh Thiruganasambandamoorthy; Andrew D Krahn; Daniel Beach; Nicolai Bodemer; Michele Brignole; Ivo Casagranda; Piergiorgio Duca; Greta Falavigna; Roberto Ippoliti; Nicola Montano; Brian Olshansky; Satish R Raj; Martin H Ruwald; Win-Kuang Shen; Ian Stiell; Andrea Ungar; J Gert van Dijk; Nynke van Dijk; Wouter Wieling; Raffaello Furlan Journal: Ann Emerg Med Date: 2014-06-02 Impact factor: 5.721
Authors: Venkatesh Thiruganasambandamoorthy; Ian G Stiell; Marco L A Sivilotti; Heather Murray; Brian H Rowe; Eddy Lang; Andrew McRae; Robert Sheldon; George A Wells Journal: BMC Emerg Med Date: 2014-03-14
Authors: Jennifer L White; Judd E Hollander; Anna Marie Chang; Daniel K Nishijima; Amber L Lin; Erica Su; Robert E Weiss; Annick N Yagapen; Susan E Malveau; David H Adler; Aveh Bastani; Christopher W Baugh; Jeffrey M Caterino; Carol L Clark; Deborah B Diercks; Bret A Nicks; Manish N Shah; Kirk A Stiffler; Alan B Storrow; Scott T Wilber; Benjamin C Sun Journal: Am J Emerg Med Date: 2019-03-25 Impact factor: 2.469
Authors: Marc A Probst; Erik P Hess; Maggie Breslin; Dominick L Frosch; Benjamin C Sun; Marie-Noelle Langan; Lynne D Richardson Journal: Acad Emerg Med Date: 2018-02-20 Impact factor: 3.451
Authors: Marc A Probst; Erica Su; Robert E Weiss; Annick N Yagapen; Susan E Malveau; David H Adler; Aveh Bastani; Christopher W Baugh; Jeffrey M Caterino; Carol L Clark; Deborah B Diercks; Judd E Hollander; Bret A Nicks; Daniel K Nishijima; Manish N Shah; Kirk A Stiffler; Alan B Storrow; Scott T Wilber; Benjamin C Sun Journal: Ann Emerg Med Date: 2019-05-09 Impact factor: 5.721
Authors: Giorgio Costantino; Martin H Ruwald; James Quinn; Carlos A Camargo; Frederik Dalgaard; Gunnar Gislason; Tadahiro Goto; Kohei Hasegawa; Padma Kaul; Nicola Montano; Anna-Karin Numé; Antonio Russo; Robert Sheldon; Monica Solbiati; Benjamin Sun; Giovanni Casazza Journal: JAMA Intern Med Date: 2018-03-01 Impact factor: 21.873
Authors: Rohin J Krishnan; Muhammad Mukarram; Bahareh Ghaedi; Marco L A Sivilotti; Natalie Le Sage; Justin W Yan; Paul Huang; Mona Hegdekar; Eric Mercier; Marie-Joe Nemnom; Lisa A Calder; Andrew D McRae; Brian H Rowe; George A Wells; Venkatesh Thiruganasambandamoorthy Journal: CMAJ Date: 2020-10-13 Impact factor: 8.262
Authors: Venkatesh Thiruganasambandamoorthy; Marco L A Sivilotti; Natalie Le Sage; Justin W Yan; Paul Huang; Mona Hegdekar; Eric Mercier; Muhammad Mukarram; Marie-Joe Nemnom; Andrew D McRae; Brian H Rowe; Ian G Stiell; George A Wells; Andrew D Krahn; Monica Taljaard Journal: JAMA Intern Med Date: 2020-05-01 Impact factor: 21.873
Authors: Marc A Probst; Michelle P Lin; Jeremy J Sze; Erik P Hess; Maggie Breslin; Dominick L Frosch; Benjamin C Sun; Marie-Noelle Langan; Venkatesh Thiruganasambandamoorthy; Lynne D Richardson Journal: Acad Emerg Med Date: 2020-04-02 Impact factor: 3.451